CHAPTER 16 END OF LIFE ISSUES
TREATMENT LIMITATION DECISIONS
Patients are often admitted to the ICU for a period of stabilization and assessment. Over time, however, it may become clear that the patient has no prospect of meaningful recovery. Under these circumstances, a decision may be made to withdraw treatment or limit further escalation of treatment. In this setting it is important to understand that there is no medico–legal obligation to continue treatment that is futile and, indeed, to do so could be considered as assault on the patient. Treatment limitation may take a number of forms depending on individual circumstances and local practice (see Box 16.1).
Box 16.1 Potential treatment limitation options
Admitting patient to ICU but limiting time for response to treatment
(Withdrawal of active treatment if no response)
Limiting range of treatments offered (e.g. not for dialysis / ventilation / inotropes)
Not escalating treatment in face of further deterioration (e.g. ceiling on inotropes)
Not attempting resuscitation in case of cardiac arrest
MANAGING WITHDRAWAL OF TREATMENT
Fluids and nutrition are usually continued, as hydration is considered an important aspect of patient comfort.Euthanasia
UK law does not allow the practice of euthanasia. Patients who are dying should not, however, be allowed to suffer needlessly. It is permissible to administer sedative or analgesic drugs to relieve patient distress, accepting that in some cases the administration of these drugs will speed up the process of death. This is known as the ‘doctrine of double effect’. Most units would prescribe benzodiazepines or opioids for this purpose and many relatives gain comfort from the fact that the dying patient is not allowed to suffer unnecessarily. It is important in this respect, however, to distinguish between the patient’s suffering and the distress of relatives or staff. It is not acceptable to administer drugs that potentially shorten life solely to ease the distress of relatives or carers.
Do not use the term ‘withdrawal of care’. Care for both the patient and their relatives, continues throughout the process of withdrawal of life-sustaining treatment.
The withdrawal of life-sustaining therapy such as nasogastric feeding from patients in persistent vegetative state (PVS), who do not otherwise require any form of organ support, is a complex legal issue. This would normally take place outside the ICU and is beyond the scope of this book.
Confirming death in severely hypothermic patients (e.g. following cold water immersion) is very difficult. Remember ‘patients should not be declared dead until they are warm and dead’. This may require lengthy attempts at resuscitation and rewarming. If in doubt, seek senior help. (See Hypothermia, p. 224.)
